Literature DB >> 15342990

A case of juvenile myelomonocytic leukemia with concomitant cytomegalovirus infection.

Hidemi Toyoda1, Masaru Ido, Hiroki Hori, Hisayuki Hiraiwa, Masahiro Hirayama, Michihiro Kobayashi, Masahiro Ogawa, Masazumi Miyahara, Shotaro Iwamoto, Tatsuya Hayashi, Esteban C Gabazza, Koji Suzuki, Eiichi Azuma, Yoshihiro Komada.   

Abstract

Infantile cytomegalovirus (CMV)-associated disease and juvenile myelomonocytic leukemia (JMML) frequently present with similar clinical features, and thus the differential diagnosis is often difficult. An early and definite diagnosis of these disorders is required because their therapeutic approaches are very different. The authors describe a 2-month-old Japanese girl with JMML and CMV infection. The CMV antigen was detected by immunologic staining of leukocytes using the peroxidase-labeled monoclonal antibody HRP-C7. To assess clonality, the X-chromosome inactivation pattern was evaluated using polymerase chain reaction analysis of the human androgen receptor gene with or without predigestion of chromosomal DNA with HhaI or HpaII. The patient showed evidence of monoclonal origin of mononuclear cells at diagnosis. Although CMV infection mimicking JMML has previously been reported in two patients, to the authors' knowledge this is the first report describing a firm and definitive diagnosis of JMML based on the study of X-chromosome inactivation patterns.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342990     DOI: 10.1097/01.mph.0000133599.34635.90

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Diagnostic dilemma of JMML coexisting with CMV infection.

Authors:  Kriti Puri; Prashant Singh; Rashmi Ranjan Das; Rachna Seth; Ritu Gupta
Journal:  Indian J Pediatr       Date:  2010-12-31       Impact factor: 5.319

2.  Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia.

Authors:  D Hasegawa; C Bugarin; M Giordan; S Bresolin; D Longoni; C Micalizzi; U Ramenghi; A Bertaina; G Basso; F Locatelli; A Biondi; G Te Kronnie; G Gaipa
Journal:  Blood Cancer J       Date:  2013-11-15       Impact factor: 11.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.